A.P. Pharma, a specialty pharmaceutical company, has initiated a program to expand its pipeline of sustained release products, including a new program targeting the relief of post-surgical pain. The company also announced it will pursue a ...
Tags: A.P.Pharma, Pipeline Expansion
Pacira Pharmaceuticals (PCRX) has entered into a five-year agreement with US-based orthopedic device distributor CrossLink Bioscience to promote and sell EXPAREL (bupivacaine liposome injectable suspension) for postsurgical pain management ...
Tags: Pacira, Orthopedic Marketplace
Pacira Pharmaceuticals has announced the findings from two new studies supporting the use of Exparel infiltrated into the transversus abdominis plane for postsurgical pain management Presented at the 2013 Annual Meeting of the ...
Pacira Pharmaceuticals, a specialty pharmaceutical company, has launched EXPAREL (bupivacaine liposome injectable suspension) in the US. EXPAREL is indicated for administration into the surgical site to produce postsurgical analgesia. ...
Tags: pacira pharmaceuticals, EXPAREL